PRL and neoplasm: We found that patients in the CD + PRL group were characterized by younger age, larger tumor size, more clinical manifestations (including a higher incidence of menstrual disorders caused by PRL secretion), lower endocrine normalization rate, and more frequent recurrence rate, compared with patients with Cushing's disease alone.